secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2025-11-28T23:59:59+00:00
Accession:  0001493152-25-025430
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CFO Timothy Lorber resigns; Interim CEO Christopher Cooper assumes CFO role
---------------------------------------------------------------------------

- Timothy Lorber resigns as CFO effective Nov 21, 2025; will provide part-time transition through Dec 4, 2025.
- Christopher Cooper (Interim CEO) appointed CFO effective Nov 21, 2025 while company searches for permanent CFO.
- Lorber receives $20K retention bonus on Nov 21 and $10K on Dec 4; 39,854 unvested RSUs to vest on Feb 8, 2026.
- RSU vesting includes 24,854 from Aug 8, 2025 grant, 14,620 from Aug 12, 2025 grant, and 380 from June 14, 2024 grant.
- Separation Agreement includes mutual release, confidentiality, and non-disparagement provisions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315225025430/0001493152-25-025430-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315225025430/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-025430

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer